Md-76 side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Md-76. Common side effects include urticaria among females.

The phase IV clinical study is created by eHealthMe based on 4 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 16, 2022

4 people who take Md-76 and have side effects are studied.


What is Md-76?

Md-76 has active ingredients of diatrizoate meglumine; diatrizoate sodium. eHealthMe is studying from 4 Md-76 users for its effectiveness, alternative drugs and more.

Number of Md-76 reports submitted per year:

Md-76 side effects.

Md-76 side effects by time on the drug*:

< 1 month:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Burning sensation

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Drug ineffective

Md-76 side effects by gender *:

female:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Burning sensation
  3. Drug ineffective

male:

n/a

Md-76 side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Burning sensation
  2. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Drug ineffective
  2. Urticaria (rash of round, red welts on the skin that itch intensely)

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Md-76?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on diatrizoate meglumine; diatrizoate sodium (the active ingredients of Md-76) and Md-76 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Md-76:

All Md-76 side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: